Effect of low and high dose of favipiravir on ovarian and reproductive function in female rats: Biochemical and histopathological evaluation
General Physiology and Biophysics, vol.41, no.5, pp.457-463, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 41 Issue: 5
- Publication Date: 2022
- Doi Number: 10.4149/gpb_2022036
- Journal Name: General Physiology and Biophysics
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE
- Page Numbers: pp.457-463
- Keywords: Favipiravir, Ovarian tissue, Reproductive function
- Open Archive Collection: AVESIS Open Access Collection
- Erzincan Binali Yildirim University Affiliated: Yes
Abstract
Favipiravir is a drug which shows antiviral activity by inhibiting RNA-dependent RNA polymerase. Favipiravir causes severe adverse effects at high doses. The aim of this study was to investigate the effects of low and high dose favipiravir on ovarian and reproductive function in female rats. The rats were divided into three groups: HG group (healthy rats), FAV-100 group (rats administered 100 mg/kg favipiravir), and FAV-400 group (rats administered 400 mg/kg favipiravir) with 12 rats in each group. Favipiravir was administered orally twice daily for 1 week. Six rats from each group were euthanized and their ovaries were removed. Oxidative and antioxidant parameters were measured in ovarian tissues and examined histopathologically. The remaining animals were kept to breed. Animals receiving favipiravir had increased oxidant content, decreased antioxidant activity, decreased histopathological damage, infertility, and gestational delay. Favipiravir treatment should be used with caution, especially in women of reproductive age.